-
cds.ahrq.gov/sites/default/files/cds/artifact/27801/Test-Cases.xlsx
October 28, 2021 - Rule 1 Test Cases
Test Cases
Rule to Test Patient Name Specific Situation Age Current Asthma Med 1
Medications are FHIR MedicationRequest resources unless noted as a MedicationStatement resource with an appended "(S)" Current Asthma Med 2
Medications are FHIR MedicationRequest resources unless noted as a MedicationSt…
-
cds.ahrq.gov/sites/default/files/cds/artifact/27796/Test-Cases.xlsx
October 28, 2021 - Rule 1 Test Cases
Test Cases
Rule to Test Patient Name Specific Situation Age Current Asthma Med 1
Medications are FHIR MedicationRequest resources unless noted as a MedicationStatement resource with an appended "(S)" Current Asthma Med 2
Medications are FHIR MedicationRequest resources unless noted as a MedicationSt…
-
cds.ahrq.gov/sites/default/files/cds/artifact/27781/Test-Cases.xlsx
October 28, 2021 - Rule 1 Test Cases
Test Cases
Rule to Test Patient Name Specific Situation Age Current Asthma Med 1
Medications are FHIR MedicationRequest resources unless noted as a MedicationStatement resource with an appended "(S)" Current Asthma Med 2
Medications are FHIR MedicationRequest resources unless noted as a MedicationSt…
-
cds.ahrq.gov/sites/default/files/cds/artifact/27806/Test-Cases.xlsx
October 28, 2021 - Rule 1 Test Cases
Test Cases
Rule to Test Patient Name Specific Situation Age Current Asthma Med 1
Medications are FHIR MedicationRequest resources unless noted as a MedicationStatement resource with an appended "(S)" Current Asthma Med 2
Medications are FHIR MedicationRequest resources unless noted as a MedicationSt…
-
cds.ahrq.gov/sites/default/files/cds/artifact/27816/Test-Cases.xlsx
October 28, 2021 - Rule 1 Test Cases
Test Cases
Rule to Test Patient Name Specific Situation Age Current Asthma Med 1
Medications are FHIR MedicationRequest resources unless noted as a MedicationStatement resource with an appended "(S)" Current Asthma Med 2
Medications are FHIR MedicationRequest resources unless noted as a MedicationSt…
-
cds.ahrq.gov/sites/default/files/cds/artifact/27771/Test-Cases.xlsx
October 28, 2021 - Rule 1 Test Cases
Test Cases
Rule to Test Patient Name Specific Situation Age Current Asthma Med 1
Medications are FHIR MedicationRequest resources unless noted as a MedicationStatement resource with an appended "(S)" Current Asthma Med 2
Medications are FHIR MedicationRequest resources unless noted as a MedicationSt…
-
cds.ahrq.gov/sites/default/files/cds/artifact/27776/Test-Cases.xlsx
October 28, 2021 - Rule 1 Test Cases
Test Cases
Rule to Test Patient Name Specific Situation Age Current Asthma Med 1
Medications are FHIR MedicationRequest resources unless noted as a MedicationStatement resource with an appended "(S)" Current Asthma Med 2
Medications are FHIR MedicationRequest resources unless noted as a MedicationSt…
-
effectivehealthcare.ahrq.gov/sites/default/files/assessing-the-risk-of-bias_draft-report.pdf
June 02, 2011 - ASSESSING THE QUALITY OF INCLUDED STUDIES
6/09/11 1
Assessing the Risk of Bias of Individual Studies when
Comparing Medical Interventions
Introduction
In this document, we update existing AHRQ guidance for systematic reviews on assessment
of risk of bias of individual studies. As with other AHRQ method…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/zmvjborz6pkcGVzgcP5nCw
September 30, 2024 - Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement
Screening for Breast Cancer
US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force
Summary of Recommendations
See the Summary of Recommendations figure.
IMPORTANCE Among all US women, breas…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/6L2obA88s86MoZDbWtMPTU
December 01, 2011 - Vitamin D With or Without Calcium Supplementation for Prevention of Cancer and Fractures: An Updated Meta-analysis for the U.S. Preventive Services Task Force
Vitamin D With or Without Calcium Supplementation for Prevention
of Cancer and Fractures: An Updated Meta-analysis for the
U.S. Preventive Services Task Force
…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions
January 19, 2021 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Final Recommendation Statement
Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions
January 19, 2021
Recommendations made by the USPSTF are inde…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-harms-of-screening-for-breast-cancer/breast-cancer-screening-january-2016
January 11, 2016 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Evidence Summary: Harms of Screening for Breast Cancer
Breast Cancer: Screening
January 11, 2016
Recommendations made by the USPSTF are independent of the U.S. gov…
-
www.ahrq.gov/sites/default/files/publications/files/confidreportguide_1.pdf
March 01, 2016 - Confidential Physician Feedback Reports: Designing for Optimal Impact on Performance
Confidential Physician
Feedback Reports:
Designing for Optimal
Impact on Performance
Agency for Healthcare Research and Quality
Advancing Excellence in Health Care www.ahrq.gov
This guide is a practical resource designe…
-
www.ahrq.gov/sites/default/files/2025-03/singer-benneyan-phillips-report.pdf
January 01, 2025 - Final Progress Report: Engineering Highly Reliable Communication and Coordination Systems for High-Risk Patients, Referrals, and Tests
1
Title Page
Final Progress Report
Engineering Highly Reliable Communication and Coordination Systems for High-Risk Patients,
Referrals, and Tests
Principal Investigators
Sar…
-
www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/resources/final-rapid-cycle-research-guidance.pdf
June 01, 2015 - One should ask to be treated as if
they were that character and act exactly as they would for that
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_executive.pdf
April 01, 2012 - reason
such work has not yet been done is that the time from
diagnosis to visual impairment in a treated
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_technical-brief.pdf
December 01, 2014 - tolerance threshold
of photo-diagnosis
by evaluating ratio
of fluorescence
intensity between
ALA treated … Other outcomes
Followup duration: NA
Outcomes:
Ratio of fluorescence
intensity between ALA
treated … tumor tissue and
normal skin
Fluorescence intensity
variation in ALA-treated
normal skin Adverse
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2010.jsp
January 01, 2010 - Patients treated in short-term rehabilitation hospitals tend to have lower mortality rates and longer … hospitals inside the frame are similar to hospitals outside the frame, the sample hospitals can be treated … if a community hospital split, the original hospital and all newly-created community hospitals were treated
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2009.jsp
January 01, 2009 - Patients treated in short-term rehabilitation hospitals tend to have lower mortality rates and longer … hospitals inside the frame are similar to hospitals outside the frame, the sample hospitals can be treated … if a community hospital split, the original hospital and all newly-created community hospitals were treated
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2011.jsp
January 01, 2011 - Patients treated in short-term rehabilitation hospitals tend to have lower mortality rates and longer … hospitals inside the frame are similar to hospitals outside the frame, the sample hospitals can be treated … if a community hospital split, the original hospital and all newly-created community hospitals were treated